Gland Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,695.36 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.02 per cent from ₹1,486.88 crore. This corresponds to a year-on-year *(YoY) growth of 22.49 per cent.
Operating Profit
Operating Profit stands at ₹67.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.05 per cent from ₹91.98 crore. This corresponds to a year-on-year *(YoY) decline of 17.48 per cent.
PBDT
PBDT stands at ₹208.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.85 per cent from ₹206.54 crore. This corresponds to a year-on-year *(YoY) growth of 9.09 per cent.
Profit Before Tax
Profit Before Tax stands at ₹362.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.55 per cent from ₹283.91 crore. This corresponds to a year-on-year *(YoY) growth of 20.99 per cent.
Net Profit
Net Profit stands at ₹285.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 55.61 per cent from ₹183.68 crore. This represents a 39.64 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | 1.41% | 4.00% | 10.98% | 1.87% | -4.79% | 21.73% |
| Ipca Labs. | -0.81% | -0.56% | -0.35% | 3.01% | 8.12% | -1.15% |
| Ajanta Pharma | 0.31% | 1.38% | 10.26% | 17.76% | 10.38% | 10.82% |
| J B Chemicals & | -0.23% | 4.54% | 5.14% | 13.47% | 14.50% | 21.35% |
| Emcure Pharma | -0.46% | -1.74% | -4.87% | 7.25% | -2.74% | 47.52% |
| Pfizer | 2.38% | 2.41% | 10.49% | 2.74% | -8.78% | 25.36% |
| Wockhardt | 2.43% | 2.37% | 3.82% | 7.93% | -3.85% | 3.44% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : Satyanarayana Murthy Chavali
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI